NCT06732388 2026-04-13
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
157 trialsNCT03753659 2026-03-23
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT07416448 2026-02-18
NAP-C/R
Ukrainian Society of Regional Anesthesia and Pain Therapy
Phase NA Recruiting
NCT07206121 2026-02-11
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Innoblative Designs, Inc.
Phase NA Recruiting
NCT02437071 2025-12-05
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT07247565 2025-11-25
Comparative Study Between Conventional Radiofrequency Ablation vs Chemical Neurolysis of Ganglion Impar for Treatment of Chronic Non Cancer Related Coccydynia
Ain Shams University
Phase NA Active not recruiting
NCT01153035 2025-11-10
ABLATE
University of Arkansas
Phase NA Active not recruiting
NCT02558504 2025-10-02
HARMONI
Hospices Civils de Lyon
Phase 4 Completed
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT04389216 2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA Completed
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT07095803 2025-07-31
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Fudan University
Phase 2 Not yet recruiting
NCT06903208 2025-07-18
RFA for Superficial Lipomas
Columbia University
Phase NA Recruiting
NCT05142904 2025-07-17
RABITO
Rijnstate Hospital
Phase 3 Terminated
NCT04520932 2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA Recruiting
NCT04522570 2025-04-30
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
Instituto do Cancer do Estado de São Paulo
Phase NA Active not recruiting
NCT06929650 2025-04-16
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
University Health Network, Toronto
Phase NA Recruiting
NCT01792934 2025-04-15
ORCHESTRA
Radboud University Medical Center
Phase NA Active not recruiting
NCT04062721 2025-04-06
LICoRN-01
Assistance Publique - Hôpitaux de Paris
Phase 1 Not yet recruiting
NCT05003856 2025-04-02
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
M.D. Anderson Cancer Center
Phase NA Terminated
NCT05551299 2025-03-27
CARP
University of Leipzig
Phase 4 Recruiting
NCT04375891 2025-02-04
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
Baptist Health South Florida
Phase NA Active not recruiting
NCT05132205 2025-01-30
Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
Johns Hopkins University
Phase NA Completed
NCT06796348 2025-01-28
Radiofrequency Ablation Versus Hemithyroidectomy of Small Thyroid Cancers
University of Aarhus
Phase NA Not yet recruiting
NCT06756087 2025-01-01
Evaluate the Efficacy of Radiofrequency Ablation/Vertebroplasty with or Without SBRT for Treating Painful Spinal Vertebral Metastases
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Not yet recruiting
NCT04798898 2024-12-05
ISCOLIM
University of Aarhus
Phase NA Recruiting
NCT06682377 2024-11-12
SM-OCT-01
Seoul National University Hospital
Phase NA Active not recruiting
NCT06609434 2024-09-27
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
Peking University Cancer Hospital & Institute
Phase NA Not yet recruiting
NCT04047173 2024-06-17
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
Phase 3 Completed
NCT06355921 2024-04-10
RFAdesmoid
Blokhin's Russian Cancer Research Center
Phase NA Not yet recruiting
NCT06278506 2024-02-26
RESTART
Karolinska University Hospital
Phase NA Recruiting
NCT02146508 2023-12-11
EXPECT
Tenwek Hospital
Phase NA Suspended
NCT02688114 2023-09-11
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
Dallas VA Medical Center
Phase NA Completed
NCT04555265 2023-08-31
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation
Chinese University of Hong Kong
Phase NA Completed
NCT05433701 2023-08-18
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Phase NA Active not recruiting
NCT05233293 2023-08-15
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Unknown
NCT00813293 2023-06-13
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT05243082 2023-03-30
ERFA-PNET
Oslo University Hospital
Phase NA Recruiting
NCT02821754 2023-03-28
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02264548 2023-03-09
A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 1 Completed
NCT03183115 2023-03-03
RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection
E-DA Hospital
Phase NA Recruiting
NCT05028439 2023-02-21
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT03088150 2022-12-20
COLLISION
Amsterdam UMC, location VUmc
Phase NA Unknown
NCT03432299 2022-10-26
RFAforPTMC
Seoul National University Hospital
Phase NA Unknown
NCT05580224 2022-10-14
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
Seoul National University Hospital
Phase NA Unknown
NCT04698252 2022-08-08
LARA
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05485909 2022-08-03
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Sun Yat-sen University
Phase 2 Unknown
NCT02243384 2022-06-02
Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma
Southwest Hospital, China
Phase NA Completed
NCT03101475 2022-05-31
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT01340105 2022-03-21
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
Chinese University of Hong Kong
Phase NA Completed